Startups
DealForma helps biopharma business development analysts be better at industry research by providing curated data and direct analyst support. All database subscriptions include time to have us complete your data projects with experienced industry analysts. Prepare for partnering meetings, benchmark deals and funding trends, and track the technologies, products, and therapeutic areas you care about. All in an easy-to-use interface.
Learn more at dealforma.com
Learn more at dealforma.com
Overview
Location
United States, California, San Mateo
Employees
11-50
Founded date
2017
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 13, 2021 | Another Keytruda combo tops standard of care in advanced kidney cancer, posing new test for Bristol's I/O med | A decade of disasters in Alzheimer’s R&D over the last 10 years — topped by the disastrous and perhaps final fumble on the amyloid beta line by Biogen — has done little to change biopharma’s appetite for risky clinical development progr... |
| Feb 13, 2021 | Another Keytruda combo tops standard of care in advanced kidney cancer, posing new test for Bristol's I/O med | Nothing says “I love this” in biopharma quite like a big upfront deal payment. In an era when biobucks are handed around in a somewhat carefree fashion, it’s the cash down payments that tell you where the leaders in this industry are seeing... |
| Feb 13, 2021 | Another Keytruda combo tops standard of care in advanced kidney cancer, posing new test for Bristol's I/O med | Ken Frazier onstage at a dealmakers event in New York City,November 2018 The New York Times Like any good big pharma CEO, Merck’s Ken Frazier likes to paint a big, positive picture when he talks with analysts about R&D. But in his lates... |
Reviews 0
FAQ about DealForma
When was DealForma founded?
DealForma was founded in 2017.
What has the press written about DealForma?
Parsers VC has collected 4 articles mentioning DealForma, among them “Another Keytruda combo tops standard of care in advanced kidney cancer, posing new test for Bristol's I/O med” (Feb 13, 2021) and “Another Keytruda combo tops standard of care in advanced kidney cancer, posing new test for Bristol's I/O med” (Feb 13, 2021).
Is DealForma still active?
Yes, DealForma is active; its latest activity on Parsers VC dates from Jun 26, 2026.